about
MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver diseaseFocal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.Emodin prevents intrahepatic fat accumulation, inflammation and redox status imbalance during diet-induced hepatosteatosis in rats.Plasma levels of homocysteine and cysteine increased in pediatric NAFLD and strongly correlated with severity of liver damage.High concentrations of H2O2 trigger hypertrophic cascade and phosphatase and tensin homologue (PTEN) glutathionylation in H9c2 cardiomyocytes.Focal Adhesion Kinase: Insight into Molecular Roles and Functions in Hepatocellular CarcinomaLipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-γ.LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver diseaseActivation of an endothelial Notch1-Jagged1 circuit induces VCAM1 expression, an effect amplified by interleukin-1β.Association between type two diabetes and non-alcoholic fatty liver disease in youth.Circulating miRNA profiling to identify biomarkers of dysmetabolism.Dual role of microRNAs in NAFLD.Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines.The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications.Markers of activated inflammatory cells correlate with severity of liver damage in children with nonalcoholic fatty liver disease.Intrauterine growth retardation and nonalcoholic Fatty liver disease in children.Glutathionylation of p65NF-kappaB correlates with proliferating/apoptotic hepatoma cells exposed to pro- and anti-oxidants.Low Birthweight Increases the Likelihood of Severe Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease.Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat.Arterial Stiffness, Thickness and Association to Suitable Novel Markers of Risk at the Origin of Cardiovascular Disease in Obese ChildrenA 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease.Levels of serum ceruloplasmin associate with pediatric nonalcoholic fatty liver disease.Commentary: FGF21 holds promises for treating obesity-related insulin resistance and hepatosteatosis.Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease.Redox homeostasis and posttranslational modifications/activity of phosphatase and tensin homolog in hepatocytes from rats with diet-induced hepatosteatosis.Increase of Intracellular Cyclic AMP by PDE4 Inhibitors Affects HepG2 Cell Cycle Progression and Survival.Plasma Cathepsin D Levels: A Novel Tool to Predict Pediatric Hepatic InflammationPlasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver diseaseA review of the pathogenic and therapeutic role of nutrition in pediatric nonalcoholic fatty liver diseaseTargeting FGF19 binding to its receptor system: A novel therapeutic approach for hepatocellular carcinomaRetinoids counteract insulin resistance and liver steatosis: What's the potential mechanism?Dual role of survivin in non-alcoholic fatty liver diseaseHepatic stellate cell proliferation: A potential role of protein kinase RActivation of the endotoxin/toll-like receptor 4 pathway: The way to go from nonalcoholic steatohepatitis up to hepatocellular carcinomaThe link between hepatosteatosis and cells of the immune systemToll-like receptor 4: A starting point for proinflammatory signals in fatty liver diseaseExpression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLD.Does Nox2 Overactivate in Children with Nonalcoholic Fatty Liver Disease?The Number of Liver Galectin-3 Positive Cells Is Dually Correlated with NAFLD Severity in ChildrenRelationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLD
P50
Q26852606-9518E0A3-2803-4FA0-8B4D-0D47FEE96FCFQ33652164-3DA4E403-25D0-4B3A-AF47-C4CC1EAA0F87Q34191208-0C3BD36B-01DB-4716-989C-4C6132A71A34Q34685694-CDD65788-B4BB-4B09-8B68-AE81FC457CF0Q35895372-4ACC9B46-C56D-4C0F-A495-0FAADDA1E3ABQ36244298-D96A0315-06D1-4925-B265-83E2B45C5997Q36466498-DDA39040-0616-4A76-9960-96107BC5D425Q36561514-074F3A27-5F5E-41D2-AFE6-9E3C4184FE3EQ36685371-B89815F4-482F-490D-A70F-8D69ACAF29D4Q37452752-D882340A-2BE8-4F8D-8521-9F4B578504F4Q38066239-C619E55B-541E-4876-B8D2-BCAFE683B047Q38099737-5CEAE8B0-66BB-4441-83BC-1781511E9416Q38665591-4653FEBE-3196-4D95-AAAF-1FADA0029C75Q39099711-9C49191B-96F4-4774-83B1-70FBD5012985Q39629021-4D5CA2B2-2E5A-43EA-9C3C-EEAC42F4A8B1Q39725341-33F28048-8D9D-42A2-BBD2-A7F6E0A1DAD8Q39819533-7C352B72-379F-412A-B07F-241F34BCA650Q40181436-7D3BADDB-3D05-4666-AB3A-97CA7F673C6AQ40706893-5F7A31EA-BD0C-4EFB-9CC3-07B2342C8127Q41454811-FDF89FBF-3A4D-4EBB-BFF7-898FFE7A4BADQ42236490-3120FE55-BEEC-4873-A5E9-9B73A0C5D4F0Q44599546-D1383524-CC3F-4D9B-B56A-84BA174A8B6FQ45371799-CF2A296F-4A51-408E-A201-CAA2A368F218Q50786458-862CC982-CE60-4823-AAA5-5BA774639EA1Q50788236-1791CCFE-F7BD-488A-8723-FCB243E36C2AQ51061616-48AF10AD-593C-4A00-A3E1-B2031621F437Q56507689-57EB1B46-655F-40AD-8355-F7CB48A37309Q57803934-C1B77186-4606-4EDF-A17D-681CB0C00D01Q57820524-F89906F4-E3AD-4877-A268-1D33106CA084Q62066880-F4863D85-EA61-49A5-9CE7-5FA6FF011454Q62066896-68E9003A-3A1B-47B1-8811-707E69DBCBFFQ62066926-5485E7C2-4106-457D-9F15-F654EB7FD1E9Q62066927-16827C85-E3F4-425A-BEDD-E32B2781B748Q62066945-63049775-EFAE-4C0B-8772-2EFAE15E8CEBQ62066971-1FE2C5CC-2C80-48A6-8AB2-D336033BB37FQ62066983-D84FA960-EED1-497E-A014-0A114AA26260Q64932672-2C47B6CE-9B74-49D4-80CF-B68904019067Q90306777-8C8DC25D-543A-4908-9BD2-291FAE86157AQ92130499-CBAEBD03-F28F-4D24-BA30-2C168DAB6FEFQ92625566-2E90D422-D573-46B2-ABBF-6013F07FBAA7
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nadia Panera
@ast
Nadia Panera
@en
Nadia Panera
@es
Nadia Panera
@nl
type
label
Nadia Panera
@ast
Nadia Panera
@en
Nadia Panera
@es
Nadia Panera
@nl
prefLabel
Nadia Panera
@ast
Nadia Panera
@en
Nadia Panera
@es
Nadia Panera
@nl
P106
P1153
25958319000
P21
P31
P496
0000-0002-5365-3123